Statements of Cash Flows
（Millions of Yen）
| 2017/3 | 2018/3 | 2019/3 | 2020/3 | 2021/3 | |
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Income before income taxes and minority interests | 3,144 | 4,746 | 5,838 | 3,920 | 2,840 |
| Depreciation | 795 | 817 | 906 | 912 | 1,061 |
| Impairment loss | 1 | 1 | - | - | 1 |
| Amortization of goodwill | 63 | 65 | 64 | 63 | 62 |
| Increase(decrease) in allowance for doubtful accounts | -15 | 48 | 26 | -50 | 7 |
| Increase (decrease) in provision for directors' bonuses | 3 | -0 | 0 | 3 | 0 |
| Increase(decrease) in provision for directors' retirement benefits | - | - | -8 | - | - |
| Increase (decrease) in provision for Executive share benefits (and other officers) | - | - | 72 | 24 | 89 |
| Increase (decrease) in net defined benefit liability | -1 | 5 | 5 | -5 | 9 |
| Interest and dividends income | -103 | -110 | -121 | -175 | -99 |
| Interest expenses | 0 | 0 | 0 | 10 | 26 |
| Decrease (increase) in notes and accounts receivable - trade | 88 | -2,259 | -2,331 | 3,381 | 2,661 |
| Decrease (increase) in inventories | -218 | -207 | -902 | -645 | -299 |
| Increase(decrease) in notes and accounts payable-trade | -356 | 722 | 827 | -778 | -2,000 |
| Other | 363 | 803 | 98 | -489 | -554 |
| Subtotal | 3,765 | 4,633 | 4,476 | 6,172 | 3,806 |
| Interest and dividends income recieved | 113 | 118 | 98 | 197 | 98 |
| Interest expenses paid | -0 | -0 | -0 | -8 | -26 |
| Income taxes (paid) refund | -1,086 | -785 | -1,557 | -1,490 | -836 |
| Net cash provided by (used in) operating activities | 2,792 | 3,965 | 3,017 | 4,870 | 3,041 |
| Cash flows from investing activities | |||||
| Net decrease (increase) in time deposits | 1 | -16 | 16 | - | - |
| Net decrease (increase) in trust beneficiary right | -126 | -87 | 74 | 101 | 315 |
| Net decrease (increase) in short-term investment securities | 300 | 300 | - | - | - |
| Purchases of property,plant and equipment and intangible assets | -394 | -499 | -558 | -1,765 | -1,711 |
| Proceeds from sales of property, plant and equipment and intangible assets | 7 | 32 | 2 | 1 | 10 |
| Purchases of investment securities | - | - | - | -280 | -70 |
| Proceeds from sales and redemptions of investments securities | 8 | 1 | 0 | 0 | 14 |
| Payments for investments in capital | - | - | - | - | -593 |
| Payments of loans receivable | -1 | - | - | -0 | - |
| Collection of loans receivable | 26 | 1 | 0 | 0 | 0 |
| Other | - | - | -98 | - | - |
| Net cash provided by (used in) investing activities | -178 | -269 | -562 | -1,942 | -2,034 |
| Cash flows from financing activities | |||||
| Cash dividends paid | -798 | -1,002 | -1,372 | -1,562 | -1,288 |
| Net increase (decrease) in short-term borrowings | - | - | - | 234 | -99 |
| Proceeds from long-term loans payable | - | - | - | 471 | - |
| Repayment of long-term loans payble | -86 | - | - | -30 | -53 |
| Purchase of treasury shares | -0 | -1 | -0 | ‐0 | -0 |
| Proceeds from disposal of treasury shares | 106 | 3 | - | 0 | - |
| Other | -8 | -18 | -26 | -44 | -60 |
| Net cash provided by (used in) financing activities | -787 | -1,019 | -1,399 | -931 | -1,503 |
| Effect of exchange rate change on cash and cash equivalents | -168 | 31 | -89 | -146 | 277 |
| Net increase(decrease) in cash and cash equivalents | 1,657 | 2,709 | 965 | 1,850 | -218 |
| Cash and cash equivanents and beginning of year | 9,596 | 11,254 | 13,963 | 14,929 | 16,779 |
| Cash and cash equivanents of newly consolidated subsidiaries（Increase in cash and cash equivalents resulting from merger with unconsolidated subsidiaries） | - | - | - | - | 740 |
| Cash and cash equivalents at end of period |
11,254 | 13,963 | 14,929 | 16,779 | 17,301 |
- ＊1 The Financial Statements have been compiled based on the items disclosed in the Summary of Financial Results for each report period, and the items presented have been based on the most recent Summary of Financial Results. Therefore, the items presented in the form of a bar (“-“) may be included under the category "Other."
- ＊2 2019/3 was an irregular 15-month fiscal period for overseas consolidated subsidiaries.